MONTECET
Montelukast Sodium is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT1 receptor.
Levocetirizine HCL, is an orally active H1-receptor antagonist.
35 mg Modified Release Tablet
Fatty Acid Oxidation (pFOX) Inhibitor
STORAGE CONDITION:
Store at temperatures not exceeding 30°c.
FORMULATION:
Each modified-release tablet contains:
Trimetazidine Hydrochloride…………………………………….35 mg
DOSAGE:
The usual dose is 35 mg two times daily with meals in the morning and evening or as prescribed by the physician.
For the treatment of Angina Pectoris and in ischemia of neurosensorial tissues.
FDA Registration Number: DRP-7640-03
Manufacturer: Lloyd Laboratories, Inc.
© 2019, Quadgen Pharmaceutical. All rights reserved. Developed by JG DevArt.